IBM and Inclusive Brains have initiated a collaborative partnership to enhance the performance of brain-machine interfaces by integrating advanced AI and quantum machine learning techniques. This joint study aims to develop technology for personalized machine-user interactions, moving from generic to bespoke solutions that cater to individual needs and cognitive diversity. The initiative will focus on responsible technology use, ethical considerations, and advancing healthcare accessibility. By leveraging IBM's AI and quantum expertise, the partnership seeks to improve brain activity classification accuracy, ultimately offering users greater autonomy and agency.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.